Results 51 to 60 of about 5,890 (202)

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

Contact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli, Khadija Mansour, Ghada Jaouahdou, Manel Ben Belgacem, Yosra Soua, Nadia Ben Fredj, Jameleddine Zili, Haifa Ben Romdhane, Karim Aouam   +8 more
wiley   +1 more source

Use of GnRH Agonist in Dogs Affected with Leishmaniosis

Animals, 2021
Sex-associated hormones such as testosterone have been demonstrated to modulate immune responses, which can result in different disease outcomes. The present study was aimed at evaluating the efficacy of a gonadotropin-releasing hormone GnRH agonist ...
Michela Pugliese, Vito Biondi, Marco Quartuccio, Santo Cristarella, Giovanni Emmanuele, Gabriele Marino, Luigi Liotta, Annamaria Passantino   +7 more
doaj   +1 more source

Meta-analyzis of studies directly comparing meglumine antimoniate and miltefosine for the treatment of ML.

, 2022
Meta-analyzis of studies directly comparing meglumine antimoniate and miltefosine for the treatment of ML.
Carolina Senra Alves de Souza (14135884), Sarah Nascimento Silva (8987663), Mariana Lourenço Freire (6996530), Líndicy Leidicy Alves (14135881), Janaína de Pina Carvalho (12152812), Gláucia Cota (4679719)   +5 more
core   +1 more source

Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis

Stem Cell Research & Therapy, 2020
Background Leishmaniasis is a neglected disease caused by Leishmania spp. One of its characteristics is an imbalance of host immune responses to foster parasite survival.
Tadeu Diniz Ramos, Johnatas Dutra Silva, Alessandra Marcia da Fonseca-Martins, Juliana Elena da Silveira Pratti, Luan Firmino-Cruz, Diogo Maciel-Oliveira, Julio Souza Dos-Santos, João Ivo Nunes Tenorio, Almair Ferreira de Araujo, Célio Geraldo Freire-de-Lima, Bruno Lourenço Diaz, Fernanda Ferreira Cruz, Patricia Rieken Macedo Rocco, Herbert Leonel de Matos Guedes   +13 more
doaj   +1 more source

An Unusual Presentation of Cutaneous Leishmaniasis in a Patient with Substance Use: A Diagnostic and Management Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT In patients with atypical ulcers and travel history to endemic areas, a comprehensive diagnostic workup for cutaneous leishmaniasis is imperative. This case confirms Leishmania tropica through combined microscopy, culture, and PCR, leading to successful treatment with systemic glucantime and adjunctive wound care.
Hossein Pazoki, Eissa Soleymani, Shirafkan Kordi, Mahdi Fakhar   +3 more
wiley   +1 more source

Comparison of low-dose meglumine antimoniate/ allopurinol combination therapy with full dose meglumine antimoniate alone in the treatment of cutaneous leishmaniasis – A randomized controlled trial

, 2016
Objective To compare the efficacy and safety of meglumine antimoniate 20 mg/kg/day with combination of meglumine antimoniate 10 mg/kg/day and allopurinol 20 mg/kg/day.
Arfan Ul Bari, Noor Ur Rasool Qadir, Naveed Malik, Amer Ejaz   +3 more
core   +1 more source

Agrarian counterpoint

American Ethnologist, Volume 53, Issue 2, Page 171-182, May 2026.
Abstract In Colombia's northeastern borderlands, agrarian economies shape how disease risk and stigma are understood and managed. As shown in ethnographic fieldwork in and around the Catatumbo region, cutaneous leishmaniasis—a sandfly‐transmitted disease that produces chronic skin lesions—appears in two radically different guises across adjacent ...
Javier Lezaun, Lina Pinto‐García
wiley   +1 more source

Critically Appraised Topic on Canine Leishmaniosis: Does Treatment with Antimonials and Allopurinol Have the Same Clinical and Clinicopathological Efficacy as Treatment with Miltefosine and Allopurinol, after One Month of Treatment?

Veterinary Sciences
The treatment of canine leishmaniosis commonly involves meglumine antimoniate with allopurinol or miltefosine with allopurinol. This study aims to compare the clinical and clinicopathological efficacy at 28–30 days of conventional dosing regimens for ...
Marina García, Lluís Ferrer, Laura Ordeix   +2 more
doaj   +1 more source

Leishmaniasis and AIDS coinfection [PDF]

Anais Brasileiros de Dermatologia, 2013
Cutaneous leishmaniasis and HIV coinfection has been reported in Brazil since the initial description of AIDS in the country. We report an HIV-positive patient under antiretroviral treatment who presented with cutaneous leishmaniasis which was ...
Adriana Hozannah, Monica Santos, Anette Chrusciak-Talhari, Carolina Talhari   +3 more
doaj   +1 more source

Knowledge mapping of risk mitigation measures against vector‐borne diseases

EFSA Journal, Volume 24, Issue 5, May 2026.
Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA), Ieva Baltusyte, Fabio Bigoni, Alessandro Broglia, Sofie Dhollander, Stefania Tampach, Jordi Figuerola, Hans Hermann Thulke, Miguel Ángel Chueca Miranda   +8 more
wiley   +1 more source